Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Committee Assignments: Little Shake-Up In The New Make-Up

Executive Summary

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

You may also be interested in...



House subcommittee posts

Republican House Energy & Commerce Committee newcomers Mike Ferguson (N.J.) and Mike Rogers (Mich.) appointed to Health Subcommittee; none of four new full committee Democrats will join (1"The Pink Sheet" Jan. 20, p. 25). Democratic Health Subcommittee vacancies will be filled by Bart Gordon (Tenn.), Diana DeGette (Colo.) and Chris John (La.). On Ways & Means/Health Subcommittee, fourth-term Texan Lloyd Doggett will fill only Democratic vacancy...

House subcommittee posts

Republican House Energy & Commerce Committee newcomers Mike Ferguson (N.J.) and Mike Rogers (Mich.) appointed to Health Subcommittee; none of four new full committee Democrats will join (1"The Pink Sheet" Jan. 20, p. 25). Democratic Health Subcommittee vacancies will be filled by Bart Gordon (Tenn.), Diana DeGette (Colo.) and Chris John (La.). On Ways & Means/Health Subcommittee, fourth-term Texan Lloyd Doggett will fill only Democratic vacancy...

Medicaid Waivers, State Relief Issues To Be Featured In House Hearings

The House Energy & Commerce Committee is planning a series of hearings on the best ways to relieve struggling state Medicaid programs

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel